How to motivate yourself to lose weight? This question torments millions of people suffering from obesity. Many do not know where to start losing weight, and in many cases, the fight against excess weight is extreme weight loss, which depletes not only the body but also psychological health. To make the weight loss process as painless as possible, research laboratories of pharmaceutical companies around the world are working to create drugs that guarantee rapid weight loss with minimal negative side effects. One such weight loss drug is an innovative combined peptide complex consisting of Cagrilintide and Semaglutide, which has been named CagriSema.

Clinical trials of the polypeptide mixture of Cagrilintide/semaglutide (abbreviated name: CagriSema) conducted in 2023 demonstrated excellent weight loss results. A 70-week course of CagriSema polypeptide therapy resulted in a 20% weight loss in overweight or obese patients.

The CagriSema weight loss drug combines the effective properties of two peptides, Semaglutide+Cagrilintide. This combination reduces weight by decreasing hunger and increasing feelings of fullness, which allows you to eat less food and significantly reduce calorie intake.

Cagrilintide is a synthetic recombinant analogue of the endogenous hormone amylin, with the distinctive feature of a longer duration of action. It has the ability to exert a parallel agonistic effect on calcitonin and amylin receptors.

Semaglutide is an antidiabetic drug used in the treatment of type II diabetes. It has been used to combat excess weight and obesity, and is also useful for long-term weight control.